Follow
Christos C. Zouboulis
Christos C. Zouboulis
Prof. Dr. med. Prof. honoraire Dr. h.c. - Staedtisches Klinikum Dessau, Brandenburg Medical School
Verified email at klinikum-dessau.de - Homepage
Title
Cited by
Cited by
Year
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
CC Zouboulis, N Desai, L Emtestam, RE Hunger, D Ioannides, I Juhász, ...
Journal of the European Academy of Dermatology and Venereology 29 (4), 619-644, 2015
11822015
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria
International Team for the Revision of the International Criteria for Behçet ...
Journal of the european Academy of Dermatology and Venereology 28 (3), 338-347, 2014
10182014
Skin anti-aging strategies
R Ganceviciene, AI Liakou, A Theodoridis, E Makrantonaki, CC Zouboulis
Dermato-endocrinology 4 (3), 308-319, 2012
9562012
New developments in our understanding of acne pathogenesis and treatment
I Kurokawa, FW Danby, Q Ju, X Wang, LF Xiang, L Xia, WC Chen, I Nagy, ...
Experimental dermatology 18 (10), 821-832, 2009
8022009
Acne and sebaceous gland function
CC Zouboulis
Clinics in dermatology 22 (5), 360-366, 2004
7782004
Two phase 3 trials of adalimumab for hidradenitis suppurativa
AB Kimball, MM Okun, DA Williams, AB Gottlieb, KA Papp, CC Zouboulis, ...
New England Journal of Medicine 375 (5), 422-434, 2016
6972016
European evidence-based (S3) guidelines for the treatment of acne.
A Nast, B Dreno, V Bettoli, K Degitz, R Erdmann, AY Finlay, ...
Journal of the European Academy of Dermatology & Venereology 26, 2012
6942012
Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study
SZ Ghodsi, H Orawa, CC Zouboulis
Journal of investigative Dermatology 129 (9), 2136-2141, 2009
6522009
Acne vulgaris
S Moradi-Tuchayi, E Makrantonaki, R Ganceviciene, C Dessinioti, ...
Nature Reviews Disease Primers 1, 15029, 2015
646*2015
What is the pathogenesis of acne?
CC Zouboulis, A Eady, M Philpott, LA Goldsmith, C Orfanos, WJ Cunliffe, ...
Exp Dermatol 14, 143-152, 2005
5492005
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial
AB Kimball, F Kerdel, D Adams, U Mrowietz, JM Gelfand, R Gniadecki, ...
Annals of internal medicine 157 (12), 846-855, 2012
5272012
Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris
T Nakatsuji, MC Kao, JY Fang, CC Zouboulis, L Zhang, RL Gallo, ...
Journal of investigative dermatology 129 (10), 2480-2488, 2009
4862009
Epidemiological features of Adamantiades-Behcet’s disease in Germany and in Europe
CC Zouboulis, I Koetter, D Djawari, W Kirch, PK Kohl, FR Ochsendorf, ...
Yonsei Med J 38, 411-422, 1997
4811997
Current use and future potential role of retinoids in dermatology
CE Orfanos, CC Zouboulis, B Almond-Roesler, CC Geilen
Drugs 53, 358-388, 1997
4731997
What causes hidradenitis suppurativa?
H Kurzen, I Kurokawa, GBE Jemec, L Emtestam, K Sellheyer, ...
Experimental Dermatology 17 (5), 455-472, 2008
460*2008
Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes
I Nagy, A Pivarcsi, K Kis, A Koreck, L Bodai, A McDowell, H Seltmann, ...
Microbes and infection 8 (8), 2195-2205, 2006
4552006
Sexual hormones in human skin
CC Zouboulis, WC Chen, MJ Thornton, K Qin, R Rosenfield
Hormone and metabolic research 39 (02), 85-95, 2007
4532007
Epidemiology of Adamantiades-Behçet's disease
CC Zouboulis
Annales de Medecine Interne 150, 488-498, 1999
4491999
Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations
PP Sfikakis, N Markomichelakis, E Alpsoy, S Assaad-Khalil, B Bodaghi, ...
Rheumatology 46 (5), 736-741, 2007
4372007
Clinical aspects and molecular diagnostics of skin aging
CC Zouboulis, E Makrantonaki
Clinics in dermatology 29 (1), 3-14, 2011
4112011
The system can't perform the operation now. Try again later.
Articles 1–20